Hanmi Pharmaceuticals Co Ltd (128940):企業の財務・戦略的SWOT分析

【英語タイトル】Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C0583)・商品コード:DATA904C0583
・発行会社(調査会社):GlobalData
・発行日:2018年7月
・ページ数:37
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Hanmi Pharmaceuticals Co Ltd (128940) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Hanmi Pharmaceuticals Co Ltd (Hanmi Pharma), a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The company’s prescription drugs include osteoporosis, antibiotics, antidiarrheal, liver supplements and antiemetics. It provides over the counter products such as vitamins, nutritional supplements and calcium supplement, among others. Hanmi Pharma’s products are used in the treatment of cancer, depression, dementia, dermatology, diabetes, anti-inflammatory, cardiovascular, epilepsy, hepatitis, hypnotics, osteoarthritis, gastrointestinal, osteoporosis and others. The company operates through its manufacturing facilities located in Hwaseong, Songpa, and Pyeongtaek, South Korea. Hanmi Pharma is headquartered in Seoul, South Korea.

Hanmi Pharmaceuticals Co Ltd Key Recent Developments

Jan 12,2017: Hanmi unveils new R&D strategy at JP Morgan Healthcare Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Hanmi Pharmaceuticals Co Ltd – Key Facts 6
Hanmi Pharmaceuticals Co Ltd – Key Employees 7
Hanmi Pharmaceuticals Co Ltd – Key Employee Biographies 8
Hanmi Pharmaceuticals Co Ltd – Major Products and Services 9
Hanmi Pharmaceuticals Co Ltd – History 10
Hanmi Pharmaceuticals Co Ltd – Company Statement 12
Hanmi Pharmaceuticals Co Ltd – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
Hanmi Pharmaceuticals Co Ltd – Business Description 15
Business Segment: Medicines 15
Overview 15
Performance 15
Business Segment: Overseas Drugs 15
Overview 15
Performance 15
Business Segment: Raw Drugs 15
Overview 15
Performance 15
Geographical Segment: China 16
Performance 16
Geographical Segment: Others 16
Performance 16
Geographical Segment: Republic of Korea 16
Performance 16
Geographical Segment: The US 16
Performance 16
R&D Overview 16
Hanmi Pharmaceuticals Co Ltd – SWOT Analysis 17
SWOT Analysis – Overview 17
Hanmi Pharmaceuticals Co Ltd – Strengths 17
Hanmi Pharmaceuticals Co Ltd – Weaknesses 18
Hanmi Pharmaceuticals Co Ltd – Opportunities 19
Hanmi Pharmaceuticals Co Ltd – Threats 20
Hanmi Pharmaceuticals Co Ltd – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Hanmi Pharmaceuticals Co Ltd, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Jan 12, 2017: Hanmi unveils new R&D strategy at JP Morgan Healthcare Conference 32
Section 6 – Appendix 33
Methodology 33
Ratio Definitions 33
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Hanmi Pharmaceuticals Co Ltd, Key Facts 6
Hanmi Pharmaceuticals Co Ltd, Key Employees 7
Hanmi Pharmaceuticals Co Ltd, Key Employee Biographies 8
Hanmi Pharmaceuticals Co Ltd, Major Products and Services 9
Hanmi Pharmaceuticals Co Ltd, History 10
Hanmi Pharmaceuticals Co Ltd, Other Locations 13
Hanmi Pharmaceuticals Co Ltd, Subsidiaries 13
Hanmi Pharmaceuticals Co Ltd, Key Competitors 21
Hanmi Pharmaceuticals Co Ltd, Ratios based on current share price 22
Hanmi Pharmaceuticals Co Ltd, Annual Ratios 23
Hanmi Pharmaceuticals Co Ltd, Annual Ratios (Cont...1) 24
Hanmi Pharmaceuticals Co Ltd, Annual Ratios (Cont...2) 25
Hanmi Pharmaceuticals Co Ltd, Interim Ratios 27
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Hanmi Pharmaceuticals Co Ltd, Recent Deals Summary 31
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36

List of Figures
Hanmi Pharmaceuticals Co Ltd, Performance Chart (2013 - 2017) 26
Hanmi Pharmaceuticals Co Ltd, Ratio Charts 28
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

★調査レポート[Hanmi Pharmaceuticals Co Ltd (128940):企業の財務・戦略的SWOT分析] (コード:DATA904C0583)販売に関する免責事項を必ずご確認ください。
★調査レポート[Hanmi Pharmaceuticals Co Ltd (128940):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆